BioPharm International Supplements, November 2010 - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

BioPharm International Supplements, November 2010
Peer-Reviewed Research
Disposable Bioreactors for Viral Vaccine Production: Challenges and Opportunities
By Jean-François Chaubard , Sandrine Dessoy , Yves Ghislain , Pascal Gerkens, PhD , Benoit Barbier , Raphael Battisti , Ludovic Peeters
Switching to single-use bioreactors can have financial and performance benefits.
Evaluation of a Single-Use Bioreactor for the Fed-Batch Production of a Monoclonal Antibody
By Emmanuelle Cameau , Georges De Abreu , Alain Desgeorges, PhD , Henri Kornmann, PhD , Elodie Charbaut, PhD
Despite different material, agitation, and aeration, the performance of the disposable bioreactor is similar to that of stainless steel bioreactors.
Implementing Single-Use Technology in Tangential Flow Filtration Systems in Clinical Manufacturing
By Keqiang Shen , Be Van Vu , Nikunj Dani , Bryan Fluke , Lei Xue , David W. Clark
A case study evaluates the performance, control of operations, productivity, and cost savings of a single-use system.
Regulatory Expectations and Consensus Industry Recommendations for Extractables Testing of Single-Use Process Equipment
By Jerold Martin
BPSA eases confusion over extractables and leachables testing through guides.
An Economic Analysis of Single-Use Tangential Flow Filtration for Biopharmaceutical Applications
By Michael LaBreck , Mark Perreault
Single-use TFF offers the greatest savings in clinical and contract manufacturing, where the scale is low and changeovers are frequent.

ADVERTISEMENT

ADVERTISEMENT

Click here